Publication
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis
dc.contributor.author | Sprague, SM | |
dc.contributor.author | Bellorin-Font, E | |
dc.contributor.author | Jorgetti, V | |
dc.contributor.author | Carvalho, AB | |
dc.contributor.author | Malluche, HH | |
dc.contributor.author | Ferreira, A | |
dc.contributor.author | D'Haese, PC | |
dc.contributor.author | Drüeke, TB | |
dc.contributor.author | Du, H | |
dc.contributor.author | Manley, T | |
dc.contributor.author | Rojas, E | |
dc.contributor.author | Moe, SM | |
dc.date.accessioned | 2018-03-15T15:40:43Z | |
dc.date.available | 2018-03-15T15:40:43Z | |
dc.date.issued | 2016-04 | |
dc.description.abstract | BACKGROUND: The management of chronic kidney disease-mineral and bone disorder requires the assessment of bone turnover, which most often is based on parathyroid hormone (PTH) concentration, the utility of which remains controversial. STUDY DESIGN: Cross-sectional retrospective diagnostic test study. SETTING & PARTICIPANTS: 492 dialysis patients from Brazil, Portugal, Turkey, and Venezuela with prior bone biopsy and stored (-20 °C) serum. INDEX TESTS: Samples were analyzed for PTH (intact [iPTH] and whole PTH), bone-specific alkaline phosphatase (bALP), and amino-terminal propeptide of type 1 procollagen (P1NP). REFERENCE TEST: Bone histomorphometric assessment of turnover (bone formation rate/bone surface [BFR/BS]) and receiver operating characteristic curves for discriminating diagnostic ability. RESULTS: The biomarkers iPTH and bALP or combinations thereof allowed discrimination of low from nonlow and high from nonhigh BFR/BS, with an area under the receiver operating characteristic curve > 0.70 but < 0.80. Using iPTH level, the best cutoff to discriminate low from nonlow BFR/BS was <103.8 pg/mL, and to discriminate high from nonhigh BFR/BS was >323.0 pg/mL. The best cutoff for bALP to discriminate low from nonlow BFR/BS was <33.1 U/L, and for high from nonhigh BFR/BS, 42.1U/L. Using the KDIGO practice guideline PTH values of greater than 2 but less than 9 times the upper limit of normal, sensitivity and specificity of iPTH level to discriminate low from nonlow turnover bone disease were 65.7% and 65.3%, and to discriminate high from nonhigh were 37.0% and 85.8%, respectively. LIMITATIONS: Cross-sectional design without consideration of therapy. Potential limited generalizability with samples from 4 countries. CONCLUSIONS: The serum biomarkers iPTH, whole PTH, and bALP were able to discriminate low from nonlow BFR/BS, whereas iPTH and bALP were able to discriminate high from nonhigh BFR/BS. Prospective studies are required to determine whether evaluating trends in biomarker concentrations could guide therapeutic decisions. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Am J Kidney Dis. 2016 Apr;67(4):559-66. | pt_PT |
dc.identifier.doi | 10.1053/j.ajkd.2015.06.023 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/2954 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Elsevier | pt_PT |
dc.subject | Adult | pt_PT |
dc.subject | Alkaline Phosphatase | pt_PT |
dc.subject | Biomarkers | pt_PT |
dc.subject | Bone Remodeling | pt_PT |
dc.subject | Bone and Bones | pt_PT |
dc.subject | Collagen Type I | pt_PT |
dc.subject | Cross-Sectional Studies | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Middle Aged | pt_PT |
dc.subject | Parathyroid Hormone | pt_PT |
dc.subject | Predictive Value of Tests | pt_PT |
dc.subject | Renal Insufficiency, Chronic | pt_PT |
dc.subject | Reproducibility of Results | pt_PT |
dc.subject | Retrospective Studies | pt_PT |
dc.subject | Renal Dialysis | pt_PT |
dc.subject | HCC NEF | pt_PT |
dc.title | Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 566 | pt_PT |
oaire.citation.issue | 4 | pt_PT |
oaire.citation.startPage | 559 | pt_PT |
oaire.citation.title | American Journal of Kidney Diseases | pt_PT |
oaire.citation.volume | 67 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |